Pandemic trials: evidence-based medicine on steroids

James D. Chalmers

doi:10.1183/13993003.04116-2020

Pandemic trials: evidence-based medicine on steroids

James D. Chalmers (Lead / Corresponding author)

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

94 Downloads (Pure)

Abstract

Small trials have been largely overlooked in the early part of the COVID-19 pandemic in favour of “mega-trials”. As new therapies are urgently needed, phase 2 “proof of concept” studies are crucial as we move into a new phase of pandemic research.

Original language	English
Article number	2004116
Number of pages	4
Journal	European Respiratory Journal
Volume	56
Issue number	6
Early online date	24 Dec 2020
DOIs	https://doi.org/10.1183/13993003.04116-2020
Publication status	Published - Dec 2020

Keywords

COVID-19
Evidence-Based Medicine
Humans
Methylprednisolone
Pandemics
SARS-CoV-2
Steroids

Access to Document

10.1183/13993003.04116-2020Licence: CC BY-NC

Final Published VersionFinal published version, 253 KBLicence: CC BY-NC

Cite this

@article{9505b93b17fc4df7b584a251618156f2,

title = "Pandemic trials: evidence-based medicine on steroids",

abstract = "Small trials have been largely overlooked in the early part of the COVID-19 pandemic in favour of “mega-trials”. As new therapies are urgently needed, phase 2 “proof of concept” studies are crucial as we move into a new phase of pandemic research.",

keywords = "COVID-19, Evidence-Based Medicine, Humans, Methylprednisolone, Pandemics, SARS-CoV-2, Steroids",

author = "Chalmers, \{James D.\}",

note = "Copyright {\textcopyright}ERS 2020 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.",

year = "2020",

month = dec,

doi = "10.1183/13993003.04116-2020",

language = "English",

volume = "56",

journal = "European Respiratory Journal",

issn = "0903-1936",

publisher = "European Respiratory Society",

number = "6",

}

TY - JOUR

T1 - Pandemic trials

T2 - evidence-based medicine on steroids

AU - Chalmers, James D.

PY - 2020/12

Y1 - 2020/12

N2 - Small trials have been largely overlooked in the early part of the COVID-19 pandemic in favour of “mega-trials”. As new therapies are urgently needed, phase 2 “proof of concept” studies are crucial as we move into a new phase of pandemic research.

AB - Small trials have been largely overlooked in the early part of the COVID-19 pandemic in favour of “mega-trials”. As new therapies are urgently needed, phase 2 “proof of concept” studies are crucial as we move into a new phase of pandemic research.

KW - COVID-19

KW - Evidence-Based Medicine

KW - Humans

KW - Methylprednisolone

KW - Pandemics

KW - SARS-CoV-2

KW - Steroids

U2 - 10.1183/13993003.04116-2020

DO - 10.1183/13993003.04116-2020

M3 - Article

C2 - 33361452

SN - 0903-1936

VL - 56

JO - European Respiratory Journal

JF - European Respiratory Journal

IS - 6

M1 - 2004116

ER -

Pandemic trials: evidence-based medicine on steroids

Abstract

Keywords

Access to Document

Fingerprint

Cite this